PT83076B - Dopamine-beta-hydroxylase inhibitors - Google Patents
Dopamine-beta-hydroxylase inhibitorsInfo
- Publication number
- PT83076B PT83076B PT83076A PT8307686A PT83076B PT 83076 B PT83076 B PT 83076B PT 83076 A PT83076 A PT 83076A PT 8307686 A PT8307686 A PT 8307686A PT 83076 B PT83076 B PT 83076B
- Authority
- PT
- Portugal
- Prior art keywords
- dopamine
- beta
- hydroxylase inhibitors
- hydroxylase
- inhibitors
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/761,936 US4634711A (en) | 1985-08-02 | 1985-08-02 | Pyridylalkyl imidazole-2-thiols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT83076A PT83076A (en) | 1986-08-01 |
| PT83076B true PT83076B (en) | 1988-07-13 |
Family
ID=25063659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT83076A PT83076B (en) | 1985-08-02 | 1986-07-28 | Dopamine-beta-hydroxylase inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4634711A (pt) |
| EP (1) | EP0214740A3 (pt) |
| JP (1) | JPS6233172A (pt) |
| AU (1) | AU592586B2 (pt) |
| DK (1) | DK357086A (pt) |
| ES (1) | ES2000587A6 (pt) |
| GR (1) | GR862032B (pt) |
| PT (1) | PT83076B (pt) |
| ZA (1) | ZA865775B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057613A (en) * | 1986-05-06 | 1991-10-15 | Merrell Dow Pharmaceuticals | Novel thione dopamine beta hydroxylase inhibitors |
| JP2581556B2 (ja) * | 1986-05-06 | 1997-02-12 | メレルダウファーマスーティカルズ インコーポレーテッド | 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤 |
| JPS63101380A (ja) * | 1986-10-17 | 1988-05-06 | Zeria Shinyaku Kogyo Kk | 新規な２−メルカプトベンズイミダゾ−ル誘導体、それらの製造法およびそれらを有効成分として含有する抗潰瘍剤 |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| US4749717A (en) * | 1987-01-08 | 1988-06-07 | Smithkline Beckman Corporation | Dopamine-beta-hydroxylase inhibitors |
| CA2036148A1 (en) * | 1990-06-29 | 1991-12-30 | Hiroki Tomioka | A 1-phenylimidazole derivative and its production and use |
| US5635521A (en) * | 1991-09-23 | 1997-06-03 | Sandoz Ltd. | Imidazolylmethyl-pyridines |
| DE4131584A1 (de) * | 1991-09-23 | 1993-03-25 | Sandoz Ag | Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika |
| GB2370229A (en) * | 2000-12-22 | 2002-06-26 | Icn Photonics Ltd | Light delivery system for improving the appearance of skin |
| WO2009097416A1 (en) * | 2008-01-29 | 2009-08-06 | Vanda Pharmaceuticals, Inc. | Imidazolylalkyl- pyridines as dbh inhibitors |
| US9567316B2 (en) | 2012-03-07 | 2017-02-14 | The Mclean Hospital Corporation | Aminoquinoline derivatives and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1509975A (fr) * | 1965-10-21 | 1968-01-19 | Geigy Ag J R | Dérivés de l'imidazole et leur préparation |
| JPS5343958B2 (pt) * | 1972-07-29 | 1978-11-24 | ||
| DE2259627A1 (de) * | 1972-12-06 | 1974-06-12 | Hoechst Ag | Imidazolyl-(2)-thio-alkansaeureester und verfahren zu ihrer herstellung |
| US4284641A (en) * | 1977-08-26 | 1981-08-18 | Burroughs Wellcome Co. | Pharmaceutically active imidazole derivatives |
| US4340738A (en) * | 1979-06-21 | 1982-07-20 | Janssen Pharmaceutica, N.V. | 2,3-Dihydro-imidazo[2,1-b]benzothiazoles |
| GR71915B (pt) * | 1979-11-27 | 1983-08-16 | Pfizer | |
| GB2096987B (en) * | 1981-04-22 | 1984-04-04 | Farmos Oy | Substituted imidazole and imidazole derivatives and their preparation and use |
| US4487761A (en) * | 1982-04-05 | 1984-12-11 | Merck & Co., Inc. | Dopamine β-hydroxylase inhibitors |
| US4506074A (en) * | 1982-11-08 | 1985-03-19 | Merck & Co., Inc. | 2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives |
| US4505918A (en) * | 1982-11-08 | 1985-03-19 | Merck & Co., Inc. | 4-[2-Pyridinylthio(oxy or amino)methyl]-1H-imidazoles and derivatives |
| PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
| US4532331A (en) * | 1983-04-12 | 1985-07-30 | Smithkline Beckman Corporation | 1-Benzyl-2-aminomethyl imidazole derivatives |
| FI833794A0 (fi) * | 1983-10-18 | 1983-10-18 | Farmos Oy | Substituerade 2-merkapto-imidazoler |
| JP2581556B2 (ja) * | 1986-05-06 | 1997-02-12 | メレルダウファーマスーティカルズ インコーポレーテッド | 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤 |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
-
1985
- 1985-08-02 US US06/761,936 patent/US4634711A/en not_active Expired - Fee Related
-
1986
- 1986-07-25 AU AU60558/86A patent/AU592586B2/en not_active Ceased
- 1986-07-28 DK DK357086A patent/DK357086A/da not_active Application Discontinuation
- 1986-07-28 EP EP86305795A patent/EP0214740A3/en not_active Withdrawn
- 1986-07-28 PT PT83076A patent/PT83076B/pt unknown
- 1986-07-29 JP JP61179811A patent/JPS6233172A/ja active Pending
- 1986-07-31 ES ES8600770A patent/ES2000587A6/es not_active Expired
- 1986-07-31 GR GR862032A patent/GR862032B/el unknown
- 1986-08-01 ZA ZA865775A patent/ZA865775B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA865775B (en) | 1987-04-29 |
| DK357086D0 (da) | 1986-07-28 |
| EP0214740A3 (en) | 1988-03-30 |
| AU6055886A (en) | 1987-02-05 |
| JPS6233172A (ja) | 1987-02-13 |
| GR862032B (en) | 1986-12-24 |
| US4634711A (en) | 1987-01-06 |
| EP0214740A2 (en) | 1987-03-18 |
| AU592586B2 (en) | 1990-01-18 |
| DK357086A (da) | 1987-02-03 |
| PT83076A (en) | 1986-08-01 |
| ES2000587A6 (es) | 1988-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3662194D1 (en) | Lipoxygenase inhibitors | |
| ZA884838B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA883851B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83076A (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83628A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA874396B (en) | Irreversible dopamine-beta-hydroxylase inhibitors | |
| ZA889667B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA889709B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA876394B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT84904A (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT83626B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA882100B (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT86513A (en) | Dopamine-beta-hydroxylase inhibitors | |
| PT81973A (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA863425B (en) | 2-substituted-1-naphthols as 5-lipoxygenase inhibitors | |
| ZA882275B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA842963B (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZW4285A1 (en) | Dopamine-beta-hydroxylase inhibitors | |
| ZA842962B (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE852330L (en) | Ó-d-mannosidase inhibitor | |
| IE852172L (en) | L - glucosidase inhibitor | |
| CS74285A1 (en) | Smesny vyparovaci inhibitor koroze kovu | |
| IE880860L (en) | Dopamine-beta-hydroxylase inhibitors | |
| IE882030L (en) | Dopamine-beta-hydroxylase inhibitors | |
| CS74385A1 (en) | Inhibitor koroze kovu pro prostredky docasne ochrany |